BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16782007)

  • 1. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression.
    Yamamoto T; Ebisuya M; Ashida F; Okamoto K; Yonehara S; Nishida E
    Curr Biol; 2006 Jun; 16(12):1171-82. PubMed ID: 16782007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells.
    Monje PV; Bartlett Bunge M; Wood PM
    Glia; 2006 Apr; 53(6):649-59. PubMed ID: 16470843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.
    Mercer K; Giblett S; Oakden A; Brown J; Marais R; Pritchard C
    Oncogene; 2005 Aug; 24(33):5207-17. PubMed ID: 15856007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
    Wang X; Lu R; Fang JY
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
    Meloche S; Pouysségur J
    Oncogene; 2007 May; 26(22):3227-39. PubMed ID: 17496918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. La(3+)-induced extracellular signal-regulated kinase (ERK) signaling via a metal-sensing mechanism linking proliferation and apoptosis in NIH 3T3 cells.
    Yu S; Hu J; Yang X; Wang K; Qian ZM
    Biochemistry; 2006 Sep; 45(37):11217-25. PubMed ID: 16964983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry.
    Korotayev K; Chaussepied M; Ginsberg D
    Cell Signal; 2008 Jun; 20(6):1221-6. PubMed ID: 18396012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells.
    Pellegrino MJ; Stork PJ
    J Neurochem; 2006 Dec; 99(6):1480-93. PubMed ID: 17223854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.
    Kim SJ; Kim SY; Kwon CH; Kim YK
    Growth Factors; 2007 Apr; 25(2):77-86. PubMed ID: 17852407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly.
    van der Meijden CM; Lapointe DS; Luong MX; Peric-Hupkes D; Cho B; Stein JL; van Wijnen AJ; Stein GS
    Cancer Res; 2002 Jun; 62(11):3233-43. PubMed ID: 12036939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of gene expression profile of G1/S transition in gastric cancer cell cycle].
    Lan B; Liu BY; Zhang J; Wang KK; Chen XH; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):229-33. PubMed ID: 16167235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor at S phase induces G2 delay through sustained ERK activation.
    Park YY; Nam HJ; Lee JH
    Biochem Biophys Res Commun; 2007 Apr; 356(1):300-5. PubMed ID: 17349975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
    Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
    Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for ERK MAP kinase in mouse preimplantation development.
    Maekawa M; Yamamoto T; Kohno M; Takeichi M; Nishida E
    Development; 2007 Aug; 134(15):2751-9. PubMed ID: 17611221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.